VKTX
Viking Therapeutics Inc
Price:  
31.63 
USD
Volume:  
2,628,418.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VKTX Intrinsic Value

-118.05 %
Upside

What is the intrinsic value of VKTX?

As of 2025-07-16, the Intrinsic Value of Viking Therapeutics Inc (VKTX) is -5.71 USD. This VKTX valuation is based on the model Peter Lynch Fair Value. With the current market price of 31.63 USD, the upside of Viking Therapeutics Inc is -118.05%.

Is VKTX undervalued or overvalued?

Based on its market price of 31.63 USD and our intrinsic valuation, Viking Therapeutics Inc (VKTX) is overvalued by 118.05%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

31.63 USD
Stock Price
-5.71 USD
Intrinsic Value
Intrinsic Value Details

VKTX Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -5.71 - -5.71 -5.71 -118.05%
P/E (20.00) - (27.75) (24.75) -178.2%
DDM - Stable (7.60) - (27.77) (17.69) -155.9%
DDM - Multi (0.19) - (0.54) (0.28) -100.9%

VKTX Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 3,552.37
Beta 1.35
Outstanding shares (mil) 112.31
Enterprise Value (mil) 3,514.43
Market risk premium 4.60%
Cost of Equity 11.11%
Cost of Debt 5.00%
WACC 7.39%